InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Preferred Shares (2016 - 2017)

InflaRx's (IFRX) quarterly Preferred Shares came in at $67.5 million in Q3 2017, up 16.95% quarter-over-quarter from $57.7 million in Q4 2016.

Analysis

InflaRx (IFRX) Preferred Shares (2016 - 2017) Analysis & Trends

InflaRx has disclosed Preferred Shares across 2 years of filings, most recently posting $67.5 million for Q3 2017.

  • In Q3 2017, Preferred Shares changed N/A year-over-year to $67.5 million; the TTM figure through Sep 2017 stood at $67.5 million (changed N/A YoY), while the FY2016 annual figure was $59.2 million, changed N/A from the prior year.
  • Preferred Shares came in at $67.5 million for Q3 2017 at InflaRx, up from $57.7 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $67.5 million in Q3 2017 to a low of $57.7 million in Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 67.48 Mn
Dec 31, 2016 57.70 Mn